Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

Eleftheria Lamprianidou, Costas Tsatalas, Paraskevi Miltiades, Theodoros Vassilakopoulos, Athanasios G. Galanopoulos, Sotirios G Papageorgiou, Vassilia Garypidou, Sofia Vakalopoulou, MD, Emmanouil Spanoudakis, Dimitrios Margaritis, Ioannis Kotsianidis

Blood (2013) 122 (21): 1509.

https://doi.org/10.1182/blood.V122.21.1509.1509

Published: 2013

Journal Articles

The Diagnostic Value of CD1d Expression In Leukemic B-Chronic Lymphoproliferative Disorders (B-CLPDs)

Eleytherios Moustakidis, Emmanuil Spanoudakis, Irene Bouchliou, Evangelia Nakou, Paraskevi Miltiades, asiliki Kotoula, V, Dimitrios Margaritis, George Bourikas, Richard Szydlo, Anastasios Karadimitris, Konstantinos Tsatalas, MD, PhD, Ioannis Kotsianidis, MD, PhD

Blood (2010) 116 (21): 3576.

https://doi.org/10.1182/blood.V116.21.3576.3576

Published: 2010

Journal Articles

Over-Expression of RANKL In Invariant NKT Cells Is Characteristic of Active Myeloma but Not of MGUS or Asymptomatic Myeloma

Emmanouil Spanoudakis, Menelaos Papoutselis, Ioannis Kotsianidis, Evangelos Terpos, Meletios A. Dimopoulos, Ming Hu, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Dimitrios Margaritis, Georgios Bourikas, Konstantinos Tsatalas, Anastasios Karadimitris

Blood (2010) 116 (21): 4049.

https://doi.org/10.1182/blood.V116.21.4049.4049

Published: 2010

Journal Articles

Correllation of Proteolytic Matrix Metalloproteases (MMPs) and Inhibitors (TIMPs) with JAK2V617F Mutation and Clinical Phenotype in BCR-ABL Negative Myeloproliferative Neoplasia (MPN).

C. M. Vadikolia, K. Anagnostopoulos, Despina Pantelidou, MD, PhD, G. Tripsianis, Emmanouil Spanoudakis, MD, PhD, Ioanna Bazdiara, Athanasios Anastasiadis, Dimitrios Margaritis, MD, PhD, A. Kortsaris, C. Tsatalas, Georgios Bourikas

Blood (2009) 114 (22): 1899.

https://doi.org/10.1182/blood.V114.22.1899.1899

Published: 2009

Journal Articles

Dynamics of Telomere Length and Telomerase Activity in Ph 1 -Negative Chronic Myeloproliferative Disorders

Ioanna Bazdiara, Despina Pantelidou, Athanasios Anastasiadis, Vassilios Papadopoulos, Dimitrios Margaritis, Emmanouil Spanoudakis, Georgios Xanthopoulidis, Ioannis Kotsianidis, Anna Christoforidou, Aggelos Goutzouvelidis, Georgios Bourikas, Konstantinos Tsatalas

Blood (2008) 112 (11): 2789.

https://doi.org/10.1182/blood.V112.11.2789.2789

Published: 2008

Journal Articles

Primary Treatment with Pulsed Melphalan, Dexamethasone, Thalidomide (MDT) for Symptomatic Patients with Multiple Myeloma ≥ 75 Years of Age.

Meletios A. Dimopoulos, MD, Panagiotis Repoussis, MD, Evangelos Terpos, MD, Maria Christina Kyrtsonis, MD, Athanasios Zomas, MD, Eirini Katodritou, MD, Souzana Delibasi, MD, Amalia Vassou, MD, Athanasios Anagnostopoulos, MD, Anastasia Pouli, MD, Konstantinos Zervas, MD, Dimitrios Margaritis, MD, Nikolaos Anagnostopoulos, MD, Alice G. Maniatis, MD

Blood (2004) 104 (11): 1482.

https://doi.org/10.1182/blood.V104.11.1482.1482

Published: 2004

NARROW

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

The Diagnostic Value of CD1d Expression In Leukemic B-Chronic Lymphoproliferative Disorders (B-CLPDs)

Over-Expression of RANKL In Invariant NKT Cells Is Characteristic of Active Myeloma but Not of MGUS or Asymptomatic Myeloma

Correllation of Proteolytic Matrix Metalloproteases (MMPs) and Inhibitors (TIMPs) with JAK2V617F Mutation and Clinical Phenotype in BCR-ABL Negative Myeloproliferative Neoplasia (MPN).

Dynamics of Telomere Length and Telomerase Activity in Ph 1 -Negative Chronic Myeloproliferative Disorders

Primary Treatment with Pulsed Melphalan, Dexamethasone, Thalidomide (MDT) for Symptomatic Patients with Multiple Myeloma ≥ 75 Years of Age.

Email alerts

ASH Publications

American Society of Hematology

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

The Diagnostic Value of CD1d Expression In Leukemic B-Chronic Lymphoproliferative Disorders (B-CLPDs)

Over-Expression of RANKL In Invariant NKT Cells Is Characteristic of Active Myeloma but Not of MGUS or Asymptomatic Myeloma

Correllation of Proteolytic Matrix Metalloproteases (MMPs) and Inhibitors (TIMPs) with JAK2V617F Mutation and Clinical Phenotype in BCR-ABL Negative Myeloproliferative Neoplasia (MPN).

Dynamics of Telomere Length and Telomerase Activity in Ph 1 -Negative Chronic Myeloproliferative Disorders

Primary Treatment with Pulsed Melphalan, Dexamethasone, Thalidomide (MDT) for Symptomatic Patients with Multiple Myeloma ≥ 75 Years of Age.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only